WILLIAM A HAWKINS
CIK 1106508 · Chairman & CEO · last filed 2026-06-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$45.55M
Companies
8
Total Filings
61
Lifetime Open-Market Net
$385.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MDXG | Director | 254,931 | $4.20 | $1.07M | $0 | 9 | 2026-06-12 |
| BIIB | Director | 10,365 | $207.67 | $2.15M | $0 | 8 | 2026-06-11 |
| BVS | Director | 297,640 | $13.32 | $3.97M | $235.6K | 13 | 2026-06-04 |
| AVNS | Director | 31,197 | $24.99 | $779.6K | $0 | 3 | 2021-01-06 |
| AVANOS MEDICAL, INC. (HYH) Delisted | Director | 17,651 | — | — | $0 | 5 | 2018-05-04 |
| THORATEC CORP (THOR) Delisted | Director | 0 | — | — | $0 | 5 | 2015-10-08 |
| MDT | Chairman & CEO | 434,032 | $85.90 | $37.28M | $149.8K | 15 | 2011-06-06 |
| DLX | Director | 11,333 | $26.41 | $299.3K | $0 | 3 | 2007-06-19 |
Recent Filings · Page 4 of 7
61 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-01-08 | AVNS | Grant (A) | +5,293 | $0 | EDGAR |
| 2019-06-20 | BIIB | Grant (A) | +1,155 | $0 | EDGAR |
| 2019-01-04 | AVNS | Grant (A) | +4,248 | $0 | EDGAR |
| 2018-05-04 | AVANOS MEDICAL, INC. (HYH) Delisted | Grant (A) | +384 | $0 | EDGAR |
| 2018-01-03 | AVANOS MEDICAL, INC. (HYH) Delisted | Grant (A) | +2,946 | $0 | EDGAR |
| 2017-01-05 | AVANOS MEDICAL, INC. (HYH) Delisted | Grant (A) | +3,749 | $0 | EDGAR |
| 2016-01-06 | AVANOS MEDICAL, INC. (HYH) Delisted | Grant (A) | +4,274 | $0 | EDGAR |
| 2015-12-03 | AVANOS MEDICAL, INC. (HYH) Delisted | Grant (A) | +355 | $0 | EDGAR |
| 2015-10-08 | THORATEC CORP (THOR) Delisted | Disp (D) | −28,526 | -$1.81M | EDGAR |
| 2015-05-06 | THORATEC CORP (THOR) Delisted | Grant (A) | +4,341 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.